Compare ANIX & UBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIX | UBCP |
|---|---|---|
| Founded | 1982 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.5M | 91.6M |
| IPO Year | 2013 | 1995 |
| Metric | ANIX | UBCP |
|---|---|---|
| Price | $3.52 | $15.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 300.9K | 8.6K |
| Earning Date | 05-27-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 5.73% |
| EPS Growth | ★ 12.82 | 5.51 |
| EPS | N/A | ★ 0.33 |
| Revenue | ★ $210,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.58 |
| P/E Ratio | ★ N/A | $47.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.32 | $12.47 |
| 52 Week High | $5.46 | $17.34 |
| Indicator | ANIX | UBCP |
|---|---|---|
| Relative Strength Index (RSI) | 58.95 | 47.91 |
| Support Level | $2.48 | $14.98 |
| Resistance Level | $3.53 | $16.12 |
| Average True Range (ATR) | 0.29 | 0.46 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 59.13 | 35.61 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which include accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. The Company's primary deposit products are checking, savings, and term certificate accounts, and its primary lending products are residential mortgage, commercial, and installment loans. The bank also operates in Marshall County, West Virginia.